Follow us on:

Eco Animal Health Group deliver strong resilient performance (Interview)

ECO Animal Health Group plc (LON:EAH) CEO Marc Loomes joins DirectorsTalk to discuss results for the year ended 31st March 2021. Marc talks us through the highlights, explains the key markets and how they performed, how the pandemic impacted the group, what has driven a 44% increase in demand for Aivlosin and how Marc would describe the outlook for the company.

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets.

Find more news, interviews, share price & company profile here for:Eco Animal Health Group plc

Share this interview

Other Interviews

ECO Animal Health Group CEO David Hallas Delivering a Strong Set of Results (VIDEO) November 28, 2023
ECO Animal Health Group robust performance with encouraging growth in revenues (VIDEO) July 25, 2023
Eco Animal Health delivering on earnings and R&D progress (VIDEO) November 24, 2022
INTERVIEW: ECO Animal Health Group plc Another Strong Performance June 20, 2019
INTERVIEW: ECO Animal Healthcare Group PLC A global presence with established routes to market April 11, 2019

More News

ECO Animal Health disposes of ECOmectin® to ACME for €1.3m April 4, 2024
ECO Animal Health reports strong trading from health products globally March 21, 2024
ECO Animal Health appoints Dr. Joachim Hasenmaier as a Non-Executive Director February 12, 2024
ECO Animal Health ECOVAXXIN® trademark approved by the EU February 6, 2024
ECO Animal Health completes sale of freehold properties January 8, 2024
ECO Animal Health Group Deferred Share Option Awards to Executive Directors December 22, 2023
ECO Animal Health sees continuing revenue growth, Group revenue increasing 9% November 27, 2023
ECO Animal Health to host two Capital Markets events November 9, 2023
ECO Animal Health receives new USA and Canada label claim for Aivlosin® October 24, 2023
ECO Animal Health achieves A-rating for its ESG activities from Integrum ESG September 28, 2023

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.